Table 1.
Baseline participant and diagnostic characteristics by treatment group for the intention-to-treat sample (n = 353)
| Variable | Total | Seeking Safety (n = 176)a |
Women’s Health Education (n = 177)a |
|---|---|---|---|
| Ageb | 39.2 (9.3) | 39.3 (9.5) | 39.0 (9.1) |
| Race/ethnicityb | |||
| African American/Black | 34.0 | 33.0 | 35.0 |
| Caucasian | 45.6 | 47.16 | 44.1 |
| Latina | 6.5 | 3.98 | 9.0 |
| Multiracial | 13.3 | 15.34 | 11.3 |
| Other | 0.6 | 0.6 | 0.6 |
| Marital status | |||
| Married | 17.6 | 14.8 | 20.3 |
| Single | 36.8 | 37.5 | 36.2 |
| Divorced/separated | 45.6 | 47.7 | 43.5 |
| Years of educationb | 12.5 (2.4) | 12.7 (2.3) | 12.4 (2.6) |
| Employment | |||
| Employed | 40.2 | 40.3 | 40.1 |
| Unemployed | 55.0 | 54.6 | 55.4 |
| Student/retired/disabled | 4.8 | 5.1 | 4.5 |
| Prior alcohol/drug treatment episodes | 5.0 (7.9) | 5.1 (7.4) | 5.0 (8.2) |
| Controlled environment (past 30 days) | 25.6 | 28.2 | 23.0 |
| Currently prescribed psychotropic medicationc,d | 44.8 | 45.5 | 44.1 |
| Baseline substance dependence diagnosis | |||
| Cocaine | 70.5 | 72.7 | 68.2 |
| Stimulants | 7.7 | 8.5 | 6.8 |
| Opiates | 25.6 | 25.6 | 25.6 |
| Marijuana | 27.2 | 27.8 | 26.6 |
| Alcohol | 56.1 | 59.7 | 52.5 |
| More than one baseline substance dependence diagnosisd | 29.5 | 33.5 | 25.4 |
| Baseline 7-day abstinence rate | 46.2 | 44.1 | 46.9 |
| PTSD diagnosis (% full) | 80.4 | 76.7 | 84.2 |
| CAPS severity, total | 62.9 (19.4) | 61.6 (19.36) | 64.2 (19.4) |
| Lifetime traumatic experiences | |||
| Child physical abuse | 58.7 | 61.1 | 56.3 |
| Adult physical abuse | 84.8 | 83.4 | 86.2 |
| Child sexual abuse | 70.1 | 73.6 | 66.7 |
| Adult sexual abuse | 67.6 | 65.1 | 70.1 |
| Transportation accident | 72.7 | 72.2 | 73.3 |
| Life-threatening illness | 39.8 | 41.5 | 38.1 |
| Exposed to violent death | 19.3 | 16.5 | 22.2 |
Values are either means (with standard deviations) or percentages.
a
There were no statistical differences between treatment groups on any variable.
b
The variables were used as covariates in the models.
c
Psychotropic medication was defined as medication prescribed for an emotional, psychological or psychiatric purpose to include depression, anxiety, psychosis, mood stabilisation or sleep disturbance.
d
Variables included in randomisation stratification. CAPS, Clinician-Administered PTSD Scale; PTSD, post-traumatic stress disorder.